AMRI announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, whose parent company, Shire, is a global company that focuses its business on behavioral health, gastro intestinal diseases, rare diseases and regenerative medicine.
The agreement extends a previously existing agreement between the two companies.
The terms of the agreement are confidential.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Ineos CEO Ineos calls on European politicians to save the chemical industry.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
